|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.32 SEK | +1.97% |
|
-1.48% | +28.02% |
| 15/05 | SenzaGen AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 25/03 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
SenzaGen AB reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 41.77 million compared to SEK 15.42 million a year ago. Net loss was SEK 24.91 million compared to SEK 31.35 million a year ago.
Basic loss per share from continuing operations was SEK 1.03 compared to SEK 1.35 a year ago. Diluted loss per share from continuing operations was SEK 1.03 compared to SEK 1.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +28.02% | 20.66M | |
| -31.06% | 9.59B | |
| -6.58% | 3.21B | |
| +26.63% | 2.92B | |
| -13.96% | 2.15B | |
| -15.30% | 1.79B | |
| +74.50% | 1.47B | |
| +25.25% | 770M | |
| -2.62% | 761M | |
| -24.39% | 548M |
SENZAGEN AB 
